Scholar Rock (NASDAQ: SRRK ... announced that the National... TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today ...

AlphaQuest LLC decreased its position in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 97.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Scholar Rock’s stock is due to drop by 7.49% following the news, according to pre-market estimates. CAMBRIDGE, Mass., March 16, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical ...

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...

Join BMO and industry leaders in New York on March 25 for the BMO 2025 Obesity Summit to discuss the growing $150 billion obesity therapies market. The Summit features an exciting line-up of leaders ...

A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

The IMSD Community of Scholars Distinguished Seminar Series brings together ... and researchers to engage with cutting-edge topics spanning precision therapeutics, tumor suppressor pathways, ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

THE WEEK’S MOST POPULAR SONGS RANKED BY ROCK AND ALTERNATIVE RADIO AIRPLAY AUDIENCE IMPRESSIONS, AS MEAURED BY MEDIABASE AND PROVIDED BY LUMINATE. STATIONS ARE ELECTRONICALLY MONITORED 24 HOURS ...

Here is your 2025 hard rock + metal album release calendar and all of this week's newest albums! Each week is loaded with new rock and metal releases and keeping track of it all can be pretty ...